Balance Sheet Dive: Encompass Health Corp (EHC)’s Debt-to-Equity and Long-Term Debt/Eq Ratios

The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.

After finishing at $108.77 in the prior trading day, Encompass Health Corp (NYSE: EHC) closed at $107.13, down -1.51%. In other words, the price has decreased by -$1.51 from its previous closing price. On the day, 0.78 million shares were traded. EHC stock price reached its highest trading level at $109.3 during the session, while it also had its lowest trading level at $107.11.

Ratios:

Our goal is to gain a better understanding of EHC by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 64.51 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 27.95. For the most recent quarter (mrq), Quick Ratio is recorded 1.06 and its Current Ratio is at 1.06. In the meantime, Its Debt-to-Equity ratio is 1.25 whereas as Long-Term Debt/Eq ratio is at 1.18.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, KeyBanc Capital Markets on October 11, 2024, initiated with a Overweight rating and assigned the stock a target price of $115.

On July 10, 2024, Leerink Partners started tracking the stock assigning a Outperform rating and target price of $100.

On March 06, 2024, Barclays started tracking the stock assigning a Overweight rating and target price of $95.Barclays initiated its Overweight rating on March 06, 2024, with a $95 target price.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 20 ’25 when Tarr Mark J sold 118,384 shares for $121.53 per share. The transaction valued at 14,387,152 led to the insider holds 527,070 shares of the business.

Mark Tarr bought 118,384 shares of EHC for $14,383,656 on May 20 ’25. On May 06 ’25, another insider, Charbonneau Elissa Joy, who serves as the Chief Medical Officer of the company, sold 4,279 shares for $116.61 each. As a result, the insider received 498,974 and left with 11,958 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EHC now has a Market Capitalization of 10798382080 and an Enterprise Value of 14183874560. As of this moment, Encompass’s Price-to-Earnings (P/E) ratio for their current fiscal year is 22.12, and their Forward P/E ratio for the next fiscal year is 19.17. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.95. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.96 while its Price-to-Book (P/B) ratio in mrq is 5.01. Its current Enterprise Value per Revenue stands at 2.573 whereas that against EBITDA is 11.508.

Stock Price History:

The Beta on a monthly basis for EHC is 0.87, which has changed by 0.1694138 over the last 52 weeks, in comparison to a change of 0.16564083 over the same period for the S&P500. Over the past 52 weeks, EHC has reached a high of $123.13, while it has fallen to a 52-week low of $82.74. The 50-Day Moving Average of the stock is -9.42%, while the 200-Day Moving Average is calculated to be 2.62%.

Shares Statistics:

The stock has traded on average 853.78K shares per day over the past 3-months and 1276400 shares per day over the last 10 days, according to various share statistics. A total of 100.90M shares are outstanding, with a floating share count of 99.28M. Insiders hold about 1.51% of the company’s shares, while institutions hold 96.79% stake in the company. Shares short for EHC as of 1751241600 were 1062743 with a Short Ratio of 1.24, compared to 1748563200 on 878401. Therefore, it implies a Short% of Shares Outstanding of 1062743 and a Short% of Float of 1.1900000000000002.

Dividends & Splits

In the trailing 12 months, EHC’s forward annual dividend rate was 0.66, compared to 0.68 this year. Against a Trailing Annual Dividend Yield of 0.00606785The stock’s 5-year Average Dividend Yield is 1.24. The current Payout Ratio is 14.35% for EHC, which recently paid a dividend on 2025-07-01 with an ex-dividend date of 2025-10-01. Stock splits for the company last occurred on 2022-07-01 when the company split stock in a 1257:1000 ratio.

Leave a Reply

Your email address will not be published. Required fields are marked *

DWinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.